Annual Current Assets
$22.45 B
+$1.71 B+8.27%
December 31, 2024
Summary
- As of February 7, 2025, NVO annual total current assets is $22.45 billion, with the most recent change of +$1.71 billion (+8.27%) on December 31, 2024.
- During the last 3 years, NVO annual current assets has risen by +$9.42 billion (+72.27%).
- NVO annual current assets is now at all-time high.
Performance
NVO Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$22.45 B
-$6.78 B-23.21%
December 31, 2024
Summary
- As of February 7, 2025, NVO quarterly total current assets is $22.45 billion, with the most recent change of -$6.78 billion (-23.21%) on December 31, 2024.
- Over the past year, NVO quarterly current assets has dropped by -$3.03 billion (-11.90%).
- NVO quarterly current assets is now -23.21% below its all-time high of $29.23 billion, reached on September 30, 2024.
Performance
NVO Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
NVO Current Assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +8.3% | -11.9% |
3 y3 years | +72.3% | +72.3% |
5 y5 years | +139.7% | +139.7% |
NVO Current Assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +72.3% | -23.2% | +72.9% |
5 y | 5-year | at high | +139.7% | -23.2% | +140.5% |
alltime | all time | at high | +5760.6% | -23.2% | +5760.6% |
Novo Nordisk A/S Current Assets History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | $42.54 B(+63.9%) | $22.45 B(-23.2%) |
Sep 2024 | - | $29.23 B(+14.7%) |
Jun 2024 | - | $25.48 B(+51.3%) |
Mar 2024 | - | $16.84 B(-18.8%) |
Dec 2023 | $25.96 B(+35.5%) | $20.73 B(+2.9%) |
Sep 2023 | - | $20.14 B(+0.3%) |
Jun 2023 | - | $20.07 B(+20.3%) |
Mar 2023 | - | $16.68 B(+7.1%) |
Dec 2022 | $19.15 B(+15.5%) | $15.57 B(-1.4%) |
Sep 2022 | - | $15.79 B(+9.2%) |
Jun 2022 | - | $14.46 B(+11.3%) |
Mar 2022 | - | $12.99 B(-0.3%) |
Dec 2021 | $16.58 B(+26.8%) | $13.03 B(-8.4%) |
Sep 2021 | - | $14.23 B(+15.3%) |
Jun 2021 | - | $12.35 B(+27.6%) |
Mar 2021 | - | $9.68 B(-11.0%) |
Dec 2020 | $13.08 B(+38.1%) | $10.88 B(-6.4%) |
Sep 2020 | - | $11.62 B(+4.6%) |
Jun 2020 | - | $11.10 B(+18.9%) |
Mar 2020 | - | $9.33 B(-0.3%) |
Dec 2019 | $9.47 B(+19.5%) | $9.36 B(+0.8%) |
Sep 2019 | - | $9.29 B(+3.9%) |
Jun 2019 | - | $8.95 B(+12.9%) |
Mar 2019 | - | $7.92 B(-12.4%) |
Dec 2018 | $7.92 B(+16.3%) | $9.05 B(+7.4%) |
Sep 2018 | - | $8.42 B(-5.6%) |
Jun 2018 | - | $8.92 B(+8.1%) |
Mar 2018 | - | $8.25 B(-14.8%) |
Dec 2017 | $6.81 B(+26.8%) | $9.68 B(+7.1%) |
Sep 2017 | - | $9.04 B(-0.4%) |
Jun 2017 | - | $9.07 B(+13.5%) |
Mar 2017 | - | $7.99 B(-5.9%) |
Dec 2016 | $5.37 B(+0.0%) | $8.50 B(+9.5%) |
Sep 2016 | - | $7.76 B(-1.4%) |
Jun 2016 | - | $7.87 B(+11.6%) |
Mar 2016 | - | $7.05 B(-12.7%) |
Dec 2015 | $5.37 B(+6.9%) | $8.08 B(+4.0%) |
Sep 2015 | - | $7.77 B(+9.1%) |
Jun 2015 | - | $7.12 B(+12.9%) |
Mar 2015 | - | $6.30 B(-16.6%) |
Dec 2014 | $5.02 B(-4.0%) | $7.56 B(+7.7%) |
Sep 2014 | - | $7.02 B(+12.1%) |
Jun 2014 | - | $6.26 B(-1.5%) |
Mar 2014 | - | $6.35 B(-18.4%) |
Dec 2013 | $5.23 B(+15.8%) | $7.78 B(+5.2%) |
Sep 2013 | - | $7.40 B(+16.0%) |
Jun 2013 | - | $6.38 B(+3.7%) |
Mar 2013 | - | $6.15 B(-13.6%) |
Dec 2012 | $4.52 B(+3.3%) | $7.12 B(+0.5%) |
Sep 2012 | - | $7.08 B(+17.8%) |
Jun 2012 | - | $6.01 B(-7.6%) |
Mar 2012 | - | $6.51 B(-5.7%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2011 | $4.38 B(+1.7%) | $6.90 B(-2.6%) |
Sep 2011 | - | $7.08 B(-3.7%) |
Jun 2011 | - | $7.35 B(+9.5%) |
Mar 2011 | - | $6.71 B(+0.9%) |
Dec 2010 | $4.30 B(+1.3%) | $6.65 B(+7.3%) |
Sep 2010 | - | $6.20 B(+11.8%) |
Jun 2010 | - | $5.54 B(-2.6%) |
Mar 2010 | - | $5.69 B(-9.4%) |
Dec 2009 | $4.25 B(+4.8%) | $6.28 B(+3.0%) |
Sep 2009 | - | $6.10 B(+8.9%) |
Jun 2009 | - | $5.60 B(+10.0%) |
Mar 2009 | - | $5.10 B(-6.8%) |
Dec 2008 | $4.05 B(-11.7%) | $5.47 B(+6.7%) |
Sep 2008 | - | $5.12 B(-7.5%) |
Jun 2008 | - | $5.54 B(+6.0%) |
Mar 2008 | - | $5.22 B(+9.8%) |
Dec 2007 | $4.59 B(+8.7%) | $4.76 B(+6.9%) |
Sep 2007 | - | $4.45 B(+6.7%) |
Jun 2007 | - | $4.17 B(+11.2%) |
Mar 2007 | - | $3.75 B(+1.7%) |
Dec 2006 | $4.22 B(+18.9%) | $3.69 B(+5.6%) |
Sep 2006 | - | $3.49 B(+0.3%) |
Jun 2006 | - | $3.48 B(+13.6%) |
Mar 2006 | - | $3.06 B(-1.2%) |
Dec 2005 | $3.55 B(-1.7%) | $3.10 B(+5.9%) |
Sep 2005 | - | $2.93 B(+7.8%) |
Jun 2005 | - | $2.71 B(-4.6%) |
Mar 2005 | - | $2.84 B(-12.6%) |
Dec 2004 | $3.61 B(+17.3%) | $3.25 B(+17.8%) |
Sep 2004 | - | $2.76 B(+8.3%) |
Jun 2004 | - | $2.55 B(+1.5%) |
Mar 2004 | - | $2.51 B(-8.9%) |
Dec 2003 | $3.08 B(+23.1%) | $2.76 B(+42.0%) |
Dec 2002 | $2.50 B(+40.5%) | $1.94 B(+18.5%) |
Dec 2001 | $1.78 B(+18.2%) | $1.64 B(+4.9%) |
Dec 2000 | $1.50 B(+5.3%) | $1.56 B(-7.5%) |
Dec 1999 | $1.43 B(-36.1%) | $1.69 B(-17.4%) |
Dec 1998 | $2.24 B(+18.7%) | $2.05 B(+8.6%) |
Dec 1997 | $1.88 B(-0.9%) | $1.88 B(+1.9%) |
Dec 1996 | $1.90 B(+0.4%) | $1.85 B(+6.5%) |
Dec 1995 | $1.89 B(+45.3%) | $1.74 B(-20.0%) |
Dec 1994 | $1.30 B(-12.1%) | $2.17 B(+59.7%) |
Dec 1993 | $1.48 B(+49.7%) | $1.36 B(-19.6%) |
Dec 1992 | $990.68 M(-13.7%) | $1.69 B(+17.8%) |
Dec 1991 | $1.15 B(+13.2%) | $1.44 B(+25.0%) |
Dec 1990 | $1.01 B(+27.3%) | $1.15 B(+18.8%) |
Dec 1989 | $796.27 M(+26.4%) | $966.37 M(+36.0%) |
Dec 1988 | $629.89 M(-5.7%) | $710.80 M(+3.5%) |
Dec 1987 | $667.63 M(+29.1%) | $687.01 M(+16.1%) |
Dec 1986 | $517.16 M(+51.0%) | $591.69 M(+23.7%) |
Dec 1985 | $342.58 M(+45.0%) | $478.19 M(+24.8%) |
Dec 1984 | $236.30 M | $383.03 M |
FAQ
- What is Novo Nordisk A/S annual total current assets?
- What is the all time high annual current assets for Novo Nordisk A/S?
- What is Novo Nordisk A/S annual current assets year-on-year change?
- What is Novo Nordisk A/S quarterly total current assets?
- What is the all time high quarterly current assets for Novo Nordisk A/S?
- What is Novo Nordisk A/S quarterly current assets year-on-year change?
What is Novo Nordisk A/S annual total current assets?
The current annual current assets of NVO is $22.45 B
What is the all time high annual current assets for Novo Nordisk A/S?
Novo Nordisk A/S all-time high annual total current assets is $22.45 B
What is Novo Nordisk A/S annual current assets year-on-year change?
Over the past year, NVO annual total current assets has changed by +$1.71 B (+8.27%)
What is Novo Nordisk A/S quarterly total current assets?
The current quarterly current assets of NVO is $22.45 B
What is the all time high quarterly current assets for Novo Nordisk A/S?
Novo Nordisk A/S all-time high quarterly total current assets is $29.23 B
What is Novo Nordisk A/S quarterly current assets year-on-year change?
Over the past year, NVO quarterly total current assets has changed by -$3.03 B (-11.90%)